Bellerophon Therapeutics, Inc. Contracts & Agreements

Separation Agreement, dated as of August 3, 2023, by and between Bellerophon Therapeutics, Inc. and Parag Shah (Filed With SEC on November 14, 2023)

Separation Agreement, dated as of July 13, 2023, by and between Bellerophon Therapeutics, Inc. and Martin Dekker (Filed With SEC on November 14, 2023)

Separation Agreement, dated as of August 3, 2023, by and between Bellerophon Therapeutics, Inc. and Peter Fernandes (Filed With SEC on November 14, 2023)

Plan of Liquidation and Dissolution of Bellerophon Therapeutics, Inc (Filed With SEC on October 13, 2023)

Amended and Restated 2015 Equity Incentive Plan (Filed With SEC on June 9, 2023)

License Agreement, dated as of January 4, 2023, by and between Bellerophon Therapeutics, Inc. and Baylor BioSciences, Inc (Filed With SEC on May 15, 2023)

Separation Agreement, dated as of May 4, 2023, by and between Bellerophon Therapeutics, Inc. and Nicholas Laccona (Filed With SEC on May 5, 2023)

Form of Pre-Funded Warrant (Filed With SEC on March 6, 2023)

Subscription Agreement, dated as of March 3, 2023, by and among Bellerophon Therapeutics, Inc. and the purchaser identified on the signature pages thereto (Filed With SEC on March 6, 2023)

Form of Restricted Sock Unit Agreement under 2015 Equity Incentive Plan (Filed With SEC on January 28, 2022)

Description of Securities Registered Under Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on March 11, 2021)

Open Market Sale AgreementSM, dated July 17, 2020, by and between Bellerophon Therapeutics, Inc. and Jefferies LLC (Filed With SEC on July 17, 2020)

Underwriting Agreement by and between Bellerophon Therapeutics, Inc. and Jefferies LLC, dated May 18, 2020 (Filed With SEC on May 20, 2020)

Subscription Agreement by and between Bellerophon Therapeutics, Inc. and Puissance Life Science Opportunities Fund VI, dated May 18, 2020 (Filed With SEC on May 20, 2020)

Advisory Agreement, by and between Bellerophon Therapeutics, Inc. and Angel Pond Capital LLC, dated May 18, 2020 (Filed With SEC on May 20, 2020)

Description of Securities Registered Under Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on April 6, 2020)

Form of Securities Purchase Agreement, dated as of March 30, 2020, by and among Bellerophon Therapeutics, Inc. and the Investors (Filed With SEC on March 30, 2020)

Form of Engagement Letter (Filed With SEC on March 30, 2020)

Binding Term Sheet and Agreement for Line of Credit Facility dated December 16, 2019 between the Company and the signatories identified therein (Filed With SEC on December 17, 2019)

Form of Warrant Amendment, dated June 28, 2019 (Filed With SEC on July 1, 2019)

Underwriting Agreement, dated January 23, 2019, by and between Bellerophon Therapeutics, Inc. and H.C. Wainwright & Co (Filed With SEC on January 23, 2019)

Third Amendment to Drug Clinical Supply Agreement, dated April 23, 2018, by and between Bellerophon Pulse Technologies LLC and INO Therapeutics LLC (Filed With SEC on April 26, 2018)

Fourth Amendment to Exclusive Cross-License, Technology Transfer and Regulatory Matters Agreement, dated April 23, 2018, by and between Bellerophon Pulse Technologies LLC and INO... (Filed With SEC on April 26, 2018)

Form of Warrant Agreement (Filed With SEC on September 27, 2017)

Registration Rights Agreement, dated September 26, 2017, among the Registrant and the investors named therein (Filed With SEC on September 27, 2017)

Securities Purchase Agreement, dated September 26, 2017 , among the Registrant and the investors named therein (Filed With SEC on September 27, 2017)

********************* (Filed With SEC on May 12, 2017)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on May 12, 2017)

COMMON STOCK PURCHASE WARRANT BELLEROPHON THERAPEUTICS, INC. (Filed With SEC on May 12, 2017)

53 Frontage Road, Suite 301, Hampton, NJ 08827 l ###-###-#### l bellerophon.com (Filed With SEC on March 16, 2017)

FORM OF SECURITIES PURCHASEAGREEMENT (Filed With SEC on November 21, 2016)

FORM OF COMMON STOCK PURCHASEWARRANT BELLEROPHONTHERAPEUTICS, INC. (Filed With SEC on November 21, 2016)

As such, SectionA.5 is hereby amended and restated in its entirety to read as follows: (Filed With SEC on November 21, 2016)

430Park Avenue | New York, New York 10022 | 212 ###-###-#### | www.hcwco.com Member:FINRA/SIPC (Filed With SEC on November 10, 2016)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on November 10, 2016)

COMMON STOCK PURCHASE WARRANT BELLEROPHONTHERAPEUTICS, INC. (Filed With SEC on November 10, 2016)

BELLEROPHON THERAPEUTICS, INC. Common Stock (par value $0.01 per share) (Filed With SEC on May 27, 2016)

Acknowledged by:/s/ Parag Shah21-Sept-2015Employee SignatureDate (Filed With SEC on May 10, 2016)

AMENDED AND RESTATED EMPLOYMENT AGREEMENT (Filed With SEC on March 21, 2016)

184 Liberty Corner Road, Suite 302, Warren, NJ 07059 | 908 ###-###-#### | bellerophon.com (Filed With SEC on March 21, 2016)

SECOND AMENDMENT TO DRUG CLINICAL SUPPLY AGREEMENT AND THIRD AMENDMENT TO EXCLUSIVE CROSS-LICENSE, TECHNOLOGY TRANSFER, AND REGULATORY MATTERS AGREEMENT (Filed With SEC on January 12, 2016)

BELLEROPHON THERAPEUTICS, INC. RESTRICTED STOCK AGREEMENT (Filed With SEC on December 4, 2015)

LEASE AGREEMENT BETWEEN 184 PROPERTY OWNER, LLC, a New Jersey limited liability company, LANDLORD, -AND- BELLEROPHON THERAPEUTICS, INC. a Delaware corporation, TENANT DATED:... (Filed With SEC on November 12, 2015)

53 Frontage Road, Suite 301, Hampton, NJ 08827 | 908 ###-###-#### | bellerophon.com (Filed With SEC on November 12, 2015)

PROFESSIONAL SERVICES AGREEMENT (Filed With SEC on November 12, 2015)

SEVERANCE AND RELEASE AGREEMENT (Filed With SEC on November 12, 2015)

FIRST AMENDMENT TO SERVICES AGREEMENT (Filed With SEC on November 12, 2015)

FIRST AMENDMENT TO TRANSITION SERVICES AGREEMENT (Filed With SEC on November 12, 2015)

Exhibit A Form of Amendment to Non-Compete Agreements AMENDMENT TO AGREEMENT NOT TO COMPETE (Filed With SEC on November 12, 2015)

SECOND AMENDMENT TO EXCLUSIVE CROSS-LICENSE, TECHNOLOGY TRANSFER, AND REGULATORY MATTERS AGREEMENT (Filed With SEC on November 12, 2015)

53 Frontage Road, Suite 301, Hampton, NJ 08827 | 908 ###-###-#### | bellerophon.com (Filed With SEC on August 14, 2015)

53 Frontage Road, Suite 301, Hampton, NJ 08827 | 908 ###-###-#### | bellerophon.com (Filed With SEC on May 15, 2015)

STOCKHOLDERS AGREEMENT (Filed With SEC on March 31, 2015)

PLAN OF CONVERSION Converting Bellerophon Therapeutics LLC (a Delaware limited liability company) into Bellerophon Therapeutics, Inc. (a Delaware corporation) (Filed With SEC on March 31, 2015)

AGREEMENT AND PLAN OF MERGER (Filed With SEC on March 31, 2015)

STOCKHOLDERS AGREEMENT (Filed With SEC on March 31, 2015)

STOCKHOLDERS AGREEMENT (Filed With SEC on February 3, 2015)

BELLEROPHON THERAPEUTICS LLC 2015 EQUITY INCENTIVE PLAN (Filed With SEC on February 3, 2015)

BELLEROPHON THERAPEUTICS, INC. INCENTIVE STOCK OPTION AGREEMENT (Filed With SEC on February 3, 2015)

BELLEROPHON THERAPEUTICS, INC. NONSTATUTORY STOCK OPTION AGREEMENT (Filed With SEC on February 3, 2015)

Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions. (Filed With SEC on February 3, 2015)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on February 3, 2015)

BELLEROPHON THERAPEUTICS, INC. (a Delaware corporation) [] Shares of Common Stock FORM OF UNDERWRITING AGREEMENT Dated: [], 2015 (Filed With SEC on February 3, 2015)

FORM OF PLAN OF CONVERSION Converting Bellerophon Therapeutics LLC (a Delaware limited liability company) into Bellerophon Therapeutics, Inc. (a Delaware corporation) (Filed With SEC on February 3, 2015)

FORM OF AGREEMENT AND PLAN OF MERGER (Filed With SEC on February 3, 2015)

STOCKHOLDERS AGREEMENT (Filed With SEC on February 3, 2015)

ASSUMED AMENDED AND RESTATED IKARIA HOLDINGS, INC. 2010 LONG TERM INCENTIVE PLAN (Filed With SEC on January 13, 2015)

ASSUMED IKARIA HOLDINGS, INC. 2007 STOCK OPTION PLAN (Filed With SEC on January 13, 2015)

BELLEROPHON THERAPEUTICS LLC 2014 EQUITY INCENTIVE PLAN (Filed With SEC on January 13, 2015)

Bellerophon Therapeutics LLC Option Agreement Granted Under 2014 Equity Incentive Plan (Filed With SEC on January 13, 2015)

Category

Industry

Companies

Contracts

Bellerophon Therapeutics, Inc. Contracts & Agreements